Sativa Group joins the ACI toxicology study

As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

The toxicology study will provide safety data that is required for Novel Food dossiers validated by the FSA, and for products to remain available on the market after 31 March 2021.

Sativa and Stillcanna’s team of scientists and quality/compliance professionals in the UK and Poland have worked with the ACI to ensure it’s CBD products meet their rigorous quality management criteria.

As part of this regulatory process, the raw CBD ingredients and final products are tested by a leading third-party laboratory, and cultivation, extraction and manufacturing processes and standards are scrutinised, to ensure that Sativa is meeting safety and regulatory standards from seed through to shelf.

The Company is submitting its own novel food application for it’s portfolio of products and brands, and on behalf of White Label customers.   

Henry Lees-Buckley, Chief Executive Office of Sativa, said: “At Sativa, producing the highest quality and compliant products is our number one objective! We welcome the FSA Novel Foods accreditation process and are very pleased to be associated with the ACI In our compliance efforts”.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Sativa Group

    More articles like this

    DirectorsTalk

    CBD as a novel food: the UK’s stance post-Brexit

    The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food applications for

    DirectorsTalk

    What cannabinoids are found in CBD oils?

    CBD oils can be purely made from seeds or they can be a combination of cannabinoids, flavonoids, and terpenes. Every CBD oil is a little bit different, and you will want to make sure you read the labels

    DirectorsTalk

    How the UK CBD industry is thriving in uncertain times

    This year covid-19 has hit hard with far-reaching economic implications for countries around the world. The United Kingdom is no exception as the economy has taken the brunt of the pandemic’s negative effects. However certain markets continue to

    DirectorsTalk

    UK CBD market on a high

    Just when you thought the ‘hype’ around CBD adoption was a passing fad, UK’s nascent CBD market happens to be among the few industries maintaining an upward growth amidst the recent COVID-19 pandemic devastation in the UK economy. 

    DirectorsTalk

    How to integrate CBD oil into your diet

    The internet is awash with information and testimonies on the benefits of CBD oil and the potential that it has in alleviating a number of ailments. Whether or not some of these claims are true is yet to